Preventive Cardiology Glossary

A class of injectable medications that dramatically lower LDL cholesterol levels.

Quantitative measure of coronary artery narrowing expressed as percentage diameter reduction compared to normal vessel c...

Fat tissue immediately surrounding coronary arteries that may influence local vascular inflammation and atherosclerosis.

Additional cardiovascular benefits of medications beyond their primary mechanism of action, particularly referring to st...

Single combination medication containing multiple cardiovascular drugs to improve adherence and simplify prevention ther...

Atherosclerotic disease affecting multiple vascular territories simultaneously, indicating systemic atherothrombosis.

Statistical models used to estimate 10-year cardiovascular disease risk in adults.

Interventions to prevent cardiovascular disease in individuals without established disease.

Non-invasive measurement of arterial stiffness used as a marker of cardiovascular risk and subclinical atherosclerosis.

UK cardiovascular risk prediction tool that incorporates additional risk factors including ethnicity, chronic kidney dis...

Cholesterol carried in triglyceride-rich lipoprotein remnants, calculated as total cholesterol minus LDL and HDL cholest...

Persistent elevated risk of cardiovascular events despite optimal management of traditional risk factors.

Additional clinical factors that may warrant more intensive cardiovascular risk reduction when traditional risk assessme...

European cardiovascular risk prediction algorithm that estimates 10-year risk of fatal and non-fatal cardiovascular even...

Interventions to prevent recurrent cardiovascular events in patients with established disease.

A collaborative process between clinician and patient for cardiovascular treatment decisions, incorporating patient valu...

A classification system identifying patient populations who derive clear cardiovascular benefit from statin therapy base...

Clinical categories of patients most likely to benefit from statin therapy based on evidence from randomized controlled...

Inability to tolerate statin therapy due to adverse effects or drug interactions.

Muscle-related adverse effects attributed to statin therapy, ranging from mild myalgia to severe rhabdomyolysis, requiri...

Muscle pain or weakness attributed to statin therapy without significant elevation in creatine kinase levels.

Early atherosclerotic disease detected by imaging or laboratory tests in patients without overt cardiovascular symptoms,...

Structural or functional abnormalities in organs particularly susceptible to cardiovascular risk factors, indicating est...

Clinical concept that different medications or treatment approaches provide similar cardiovascular benefits and can be u...